English
Tesla Q1 2026 earnings preview
With Terafab in focus and deliveries disappointing, 22 April forces investors to decide what Tesla actually is.
When will Tesla report its latest earnings?
Tesla reports first quarter (Q1) 2026 results on Wednesday, 22 April at 9.00pm BST after the United States (US) close.
Company backdrop
The stock enters earnings week having just broken out of a multi‑month descending channel, up more than 7% on an artificial intelligence (AI) chip development announcement. However, the underlying fundamentals tell a more complicated story. Deliveries have already come in below expectations, margins are under pressure, and investors are increasingly grappling with how to value a company that may be in the early stages of leaving the auto business behind.
Street consensus is centred on earnings per share (EPS) of $0.37 on revenue of $22.71 billion. By contrast, Refinitiv’s Smart Estimate is more cautious, forecasting $0.30 EPS on $21.52 billion in revenue, with a predicted earnings surprise of -20.6%. The growing gap between the headline Wall Street estimate and the model‑implied downside is itself a signal worth watching.
Core Metrics snapshot
Metric |
Q1 FY26 (est.) |
Q1 FY25 (act.) |
YoY Change |
| EPS (adjusted) | $0.37 | $0.27 | +37% |
| Revenue | $22.71B | $19.34B | +17% |
| Gross Margin | ~17–18% | 16.3% | +~1–2 pts |
| Operating Margin | ~5% | 2.1% | +~3 pts |
| Vehicle Deliveries | 358,023 | 386,810 | –7% |
| 52-Week Range | $222.79 – $498.83 | — | — |
Three things the market is watching
1. Capex creep: the Terafab question
The most consequential figure on 22 April may not be EPS, but incremental capital expenditure (capex) commentary around Terafab. Tesla’s 2026 capex guidance already exceeds $20 billion, yet Terafab, the planned one‑terawatt AI compute facility, was explicitly excluded from that figure. If fully realised, Terafab could cost in the mid single‑digit trillions, a scale that dwarfs Tesla’s entire automotive revenue base.
Reuters and Bloomberg have reported that Musk’s team has contacted multiple suppliers, suggesting the project is moving beyond concept. When combined with ambitions for 100 gigawatts of solar capacity, Tesla’s investment cycle extends well beyond what the auto business can reasonably fund through operations. Management commentary on Terafab phasing and funding is therefore likely to move the stock more than the reported revenue line.
2. Margin pressure in a volume‑soft quarter
Vehicle deliveries of 358,023 in Q1 missed the Visible Alpha estimate of 368,903 units, although they recovered from Q1 2025’s 336,681, a quarter that itself marked a 13% year-on-year (YoY) decline. This volume shortfall, combined with ongoing raw material cost pressures and continued price competition in China, creates a challenging gross margin set‑up quarter-on-quarter (QoQ).
If gross margin prints below 17%, the profitability narrative deteriorates further, even if enthusiasm around Terafab continues to build.
3. The autonomy‑to‑revenue timeline
Tesla’s real inflection point lies in the transition from automotive manufacturing to physical AI, spanning Robotaxi scaling, full self‑driving (FSD) monetisation and the Optimus production ramp‑up. However, limited concrete progress on autonomy timelines in recent months has weighed on the stock and kept investors cautious.
The earnings call will be closely examined for updated guidance on commercial Robotaxi rollout dates, FSD take‑rate data and Optimus unit economics.
Analyst and client sentiment
Based on 30 analysts over the past three months, there are 13 'buy', 11 'hold' and six 'sell' ratings. The consensus remains hold, with sell‑side scepticism notably elevated relative to typical large‑cap coverage.
Tesla TipRanks Smart Score
Market buzz and headlines
- AI chip surge: Tesla shares jumped more than 7% on an AI chip development announcement, highlighting how quickly the market reprices Tesla as a physical AI story rather than a traditional auto stock
- Terafab supplier outreach: Musk’s team has contacted multiple suppliers for the Terafab chip facility, according to Reuters and Bloomberg, signalling progression beyond the concept stage
- Q1 delivery miss: 358,023 units versus 368,903 estimated. The miss was absorbed by the market but sets up a softer earnings base
- SpaceX initial public offering speculation: the Wall Street Journal and Bloomberg have reported on X restructuring and a possible SpaceX filing, introducing a parallel narrative that competes for investor attention and raises questions around Musk’s bandwidth
- National Highway Traffic Safety Administration closure: regulators closed a preliminary evaluation covering an estimated 2.59 million Tesla vehicles, providing modest regulatory relief
- Twitter litigation: a jury found Musk liable to Twitter shareholders over the $44 billion takeover, an issue that continues to surface in corporate governance assessments.
Peer snapshot and valuation
Tesla’s valuation premium to traditional original equipment manufacturers is striking, trading at roughly 35× Mercedes and 52× Volkswagen. That gap rests entirely on the physical AI thesis. If Q1 results suggest the auto business is funding an open‑ended research and development cycle without a clear profitability inflection point, that premium will be increasingly difficult to justify.
Peer snapshot and valautrion table
Company |
PE (LTM) |
EPS Growth |
ROE |
D/E |
Recent % Chg |
| Tesla | 364× | +9.6% | 4.93% | 10.2% | +7.6% |
| GM | 23.8× | –5.3% | 4.32% | 213.2% | –2.1% |
| Ford | — | +31.6% | –20.2% | 454.3% | 0.0% |
| Mercedes-Benz | 10.2× | –22.5% | 5.68% | 107.2% | — |
| Volkswagen | 6.95× | +32.8% | 3.45% | 152.1% | — |
| Rivian | — | –43.2% | –65.0% | 97.2% | +2.6% |
| APTIV | 78.2× | –13.8% | 1.95% | 82.0% | –1.0% |
Tesla technical analysis
Tesla has broken out of the descending channel that contained price action throughout early 2026, a technically significant development ahead of earnings. The stock, trading around $395.78, is now testing a resistance level that acted as a psychological ceiling during the February - March decline.
The 100‑day moving average (MA) remains bearish at -13.21%, confirming that the broader trend has not yet turned. At this stage, the move represents a channel breakout rather than a full trend reversal.
Why does this matter?
Tesla’s Q1 results force a clarity moment the market has long deferred. Is Tesla a car company with an ambitious AI side project, or an AI infrastructure company that still sells cars? The answer carries trillion‑dollar valuation implications.
If management delivers credible timelines for Terafab phasing, Robotaxi commercialisation and Optimus unit economics, without triggering concerns about deepening negative free cash flow, the stock may be able to sustain its valuation premium. If the call offers vision without near‑term financial anchoring, a multiple contraction back towards $350 - $320 becomes a realistic risk.
For now, Tesla remains the most direct public proxy for the physical AI thesis, and 22 April represents its next major stress test.
Tesla daily candlestick chart
Important to know
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Follow us online
